Poster Presentations Session I
Poster Presentations Session I Saturday, 16 September 2017
POSTERS SET-UP: 8:15 - 8:30
POSTERS DISPLAY HOURS: 8:30 - 20:00
POSTER AUTHOR DISCUSSION: 18:30 - 19:30
POSTERS DISMANTLE: 20:00


Poster display locations are shown below the poster codes
NEUROLOGICAL DISORDERS - Clinical Outcomes Studies
PND1
I11
OSTEOPATHIC MANIPULATIVE THERAPY IN PATIENTS WITH HEADACHE: SYSTEMATIC LITERATURE REVIEW
Vasconcellos JF1, Vasconcellos BC2, Fernandes RA1
1Sense Company, Rio de Janeiro, Brazil, 2CERTO Reabilitação, Rio de Janeiro, Brazil

PND2
I12
EFFECTIVENESS OF LACOSAMIDE FOR THE TREATMENT OF NON-CONTROLLED FOCAL EPILEPSY
Morita ME1, Psaltikidis EM1, Soares E1, Cendes F1, Yasuda CL1, Evangelista-Poderoso R2, Resende MR3, Betting LE4
1Clinical Hospital of State University of Campinas, Campinas, Brazil, 2Faculty of Medical Sciences of State University of Campinas, Campinas, Brazil, 3Faculty of Medical Sciences, State University of Campinas, Campinas, Brazil, 4Botucatu Medical School of the Universudade Estadual Paulista – UNESP, Botucatu, Brazil

PND3
I13
EVALUACIÓN DE EFECTIVIDAD Y SEGURIDAD DE LA TERAPIA FARMACOLÓGICA PARA EL TRATAMIENTO DE LA ENFERMEDAD DE PARKINSON INICIAL Y AVANZADA EN COLOMBIA.
Contreras J, Castro P, Sierra J, Orozco L
Universidad de Antioquia, Medellín, Colombia

NEUROLOGICAL DISORDERS - Cost Studies
PND4
I14
ANÁLISE DE CUSTO EFETIVIDADE DA TOXINA ONABOTULÍNICA A NO TRATAMENTO PREVENTIVO DA MIGRÂNEA CRÔNICA
Cadecaro P1, Pepe C2, Asano E2, Romariz G1
1Allergan, Sao Paulo, Brazil, 2Sense Company, São Paulo, Brazil

PND5
I15
ANÁLISIS DE COSTO-EFECTIVIDAD DE LA MONOTERAPIA CON RASAGILINA COMPARADA CON PRAMIPEXOL PARA EL MANEJO DE LOS SÍNTOMAS MOTORES EN PACIENTES CON ENFERMEDAD DE PARKINSON INICIAL EN COLOMBIA.
Castro P, Orozco L, Contreras J, Sierra J, Sanmartín D
Universidad de Antioquia, Medellín, Colombia

NEUROLOGICAL DISORDERS - Patient-Reported Outcomes & Patient Preference Studies
PND6
I16
RELAPSING-REMITTING MULTIPLE SCLEROSIS PATIENTS ON DIMETHYL FUMARATE REPORTED LESS PHYSICAL AND PSYCHOLOGICAL DISEASE IMPACT IN THE REAL WORLD COMPARED WITH PATIENTS ON PLATFORM THERAPIES
Huang M1, Pike J2, Huang W3, Jones E4
1Biogen, Cambridge, MA, USA, 2Adelphi Real World, Cheshire, UK, 3UCSF, San Francisco, CA, USA, 4Adelphi Real World, Manchester, UK

NEUROLOGICAL DISORDERS - Health Care Use & Policy Studies
PND7
J1
WITHDRAWN

PND8
J2
ANTICONVULSANT DRUGS USE EVALUATION SURVEY AMONG AMBULATORY EPILEPTIC PATIENTS IN A TERTIARY TEACHING HOSPITAL IN SOUTHEAST NIGERIA
Ogbonna BO, Ume IO
NNAMDI AZIKIWE UNIVERSITY, AWKA, Nigeria

PND9
J3
OBSTRUCTIVE SLEEP APNEA TREATMENT GUIDELINES - IMPLEMENTATION STATUS IN OECD-COUNTRIES
Braun M1, Heiser C2
1Inspire Medical Systems, Inc., Maple Grove, MN, USA, 2Technical University Munich, Munich, Germany

Contact ISPOR @ info@ispor.org | View Legal Disclaimer
© 2018 International Society for Pharmacoeconomics and Outcomes Research.
All rights reserved under International and Pan-American Copyright Conventions.